Hypoxia-activated KDAC inhibitor: Taking a breath from untargeted therapy
{{output}}
Use of hypoxia-activated prodrugs has emerged as a strategy for selectively targeting tumors in hypoxic conditions harboring reductive environments. In this issue of Cell Chemical Biology, Skwarska et al. (2021) report a hypoxia-activated prodrug targeting his... ...